TCR-like antibodies for intracellular cancer antigens

About Panosome

Panosome is a private, pre-clinical stage biotech company leveraging its unique VAST platform to generate antibodies against challenging antigen classes. Spun out from the German Cancer Research Center (DKFZ), the company's core technology utilizes a dense, nanoparticle-forming surface array to elicit potent immune responses. Its initial strategy is to partner with pharmaceutical companies and develop immunotherapeutics in areas like oncology, targeting antigens that have eluded conventional antibody discovery methods.

Therapeutic Areas